Association between small apolipoprotein(a) isoforms and frontotemporal dementia in humans

Neuroscience Letters

Volumn 353, Issue 3, 2003, Pages 201-204

  Emanuele, Enzo ^a   Peros, Emmanouil ^a   Tomaino, Carmine ^b   Feudatari, Enrica ^c   Bernardi, Livia ^b   Binetti, Giuliano ^c   Maletta, Raffaele ^b   Micieli, Giuseppe ^a   Bruni, Amalia Cecilia ^b   Geroldi, Diego ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Regional Center of Neurogenetics   (Italy)

^c IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

Apolipoprotein(a) isoforms; Biomarkers; Frontotemporal dementia; Susceptibility

Indexed keywords

APOLIPOPROTEIN A; ISOPROTEIN;

ADULT; AGED; ARTICLE; CAUCASIAN; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; FAMILIAL DISEASE; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PATIENT; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RISK; STATISTICAL SIGNIFICANCE;

EID: 10744222283     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.09.046     Document Type: Article

References (23)

1. Consensus Statement. Clinical and neuropathological criteria for fronto-temporal dementia. The Lund and Manchester Groups. J. Neurol. Neurosurg. Psychiatry. 4:1994;416-418.
2. Argraves K.M., Kozarsky K.F., Fallon J.T., Harpel P.C., Strickland D.K. The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor. J. Clin. Invest. 100:1997;2170-2181.
3. Boerwinkle E., Leffert C.C., Lin J., Lackner C., Chiesa G., Hobbs H.H. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J. Clin. Invest. 90:1992;52-60.
4. Dangas G., Mehran R., Harpel P.C., Sharma S.K., Marcovina S.M., Dube G., Ambrose J.A., Fallon J.T. Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation. J. Am. Coll. Cardiol. 32:1998;2035-2042.
5. Gazzaruso C., Garzaniti A., Buscaglia P., Bonetti G., Falcone C., Fratino P., Finardi G., Geroldi D. Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age. J. Am. Coll. Cardiol. 33:1999;157-163.
6. Geroldi D., Bellotti V., Buscaglia P., Bonetti G., Gazzaruso C., Caprioli A., Fratino P. Characterization of apo(a) polymorphism by a modified immunoblotting technique in an Italian population sample. Clin. Chim. Acta. 221:1993;159-169.
7. Geschwind D., Karrim J., Nelson S.F., Miller B. The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia. Ann. Neurol. 44:1998;134-138.
8. Goedert M., Crowther R.A., Spillantini M.G. Tau mutations cause frontotemporal dementias. Neuron. 21:1998;955-958.
9. Ilyas Kamboh M., Ferrel R.E., Kottke B.A. Expressed hypervariable polymorphism of apolipoprotein(a). Am. J. Hum. Genet. 49:1991;1063-1074.
10. Jurgens G., Taddei-Peters W.C., Koltringer P., Petek W., Chen Q., Greilberger J., Macomber P.F., Butman B.T., Stead A.G., Ransom J.H. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease. Stroke. 26:1995;1841-1848.
11. Koch M., Kutkuhn B., Trenkwalder E., Bach D., Grabensee B., Dieplinger H., Kronenberg F. Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients. J. Am. Soc. Nephrol. 8:1997;1889-1898.
12. Kowalska A., Takahashi K., Kozubski W., Tabira T. Microtubule associated protein (tau) gene variability in patients with frontotemporal dementia. Folia Neuropathol. 40:2002;1-5.
13. Lehmann D.J., Smith A.D., Combrinck M., Barnetson L., Joachim C. Apolipoprotein E epsilon2 may be a risk factor for sporadic frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry. 69:2000;404-405.
14. Marcovina S.M., Zhang Z.H., Gaur V.P., Albers J.J. Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. Biochem. Biophys. Res. Commun. 191:1993;1192-1196.
15. Martin J.A., Craft D.K., Su J.H., Kim R.C., Cotman C.W. Astrocytes degenerate in frontotemporal dementia: possible relation to hypoperfusion. Neurobiol. Aging. 22:2001;195-207.
16. Miller B.L., Cummings J.L., Villanueva-Meyer J., Boone K., Mehringer C.M., Lesser I.M., Mena I. Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology. 41:1991;1374-1382.
17. Miller B.L., Ikonte C., Ponton M., Levy M., Boone K., Darby A., Barman N., Mena I., Cummings J.L. A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations. Neurology. 48:1997;937-942.
18. Mooser V., Helbecque N., Miklossy J., Marcovina S.M., Nicod P., Amouyel P. Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease. Ann. Intern. Med. 132:2000;533-537.
19. Nichol K.E., Kim R., Cotman C.W. Bcl-2 family protein behavior in frontotemporal dementia implies vascular involvement. Neurology. 56:2001;S35-S40.
20. Ramharack R., Spahr M.A., Kreick J.S., Sekerke C.S. Expression of apolipoprotein[a] and plasminogen mRNAs in cynomolgus monkey liver and extrahepatic tissues. J. Lipid Res. 37:1996;2029-2040.
21. Snowden J.S., Neary D., Mann D.M. Frontotemporal dementia. Br. J. Psychiatry. 180:2002;140-143.
22. Solfrizzi V., Panza F., D'Introno A., Colacicco A.M., Capurso C., Basile A.M., Capurso A. Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 72:2002;732-736.
23. Stevens M., van Duijn C.M., de Knijff P., van Broekhoven C., Heutink P., Oostra B.A., Niemeijer M.F., van Swieten J.C. Apolipoprotein E gene and sporadic frontal lobe dementia. Neurology. 48:1997;1526-1529.